文献速递心血管MR

四维血流心脏MRI评估的左心室二尖瓣充盈受损与肥厚型心肌病预后的关联

Association of Impaired Left Ventricular Mitral Filling from 4D Flow Cardiac MRI and Prognosis of Hypertrophic Cardiomyopathy.
PubMed 文献 · Radiol Cardiothorac Imaging · 2024-01-01

在44例肥厚型心肌病患者与44名年龄性别匹配的健康志愿者中,用四维血流心脏MRI测得的峰值早期充盈率与充盈容积之比(PEFR/FV)在患者组显著降低,且与BNP及E/E'相关;中位随访2.3年,PEFR/FV≤2.61 sec⁻¹与复合终点发生独立相关。

要点

  • 肥厚型心肌病患者四维血流MRI测得的PEFR/FV较健康志愿者显著降低。
  • PEFR/FV≤2.61 sec⁻¹与复合终点发生相关,风险比最高达15.21。
  • PEFR/FV与BNP水平及超声E/E'均呈负相关。

核心结论

  • 在肥厚型心肌病中,四维血流心脏MRI评估的左心室充盈与舒张功能的多普勒及生物学指标相关,并可预测临床结局。

研究设计与样本

  • 前瞻性注册研究(ClinicalTrials.gov NCT01091480),纳入44例肥厚型心肌病患者与44名年龄性别匹配的健康志愿者,均行四维血流序列及延迟钆增强心脏MRI和超声心动图检查。

关键影像表现/征象

  • 肥厚型心肌病患者组PEFR/FV均值为3.35 sec⁻¹±0.99(范围0.90-5.20),健康志愿者组为4.42 sec⁻¹±1.68(范围2.74-11.86),患者组显著降低(P < .001)。

诊断标准与关键数值

  • PEFR/FV≤2.61 sec⁻¹与复合主要终点发生显著相关,风险比9.46(95%CI:2.61,45.17;P < .001)至15.21(95%CI:3.51,80.22;P < .001)。
  • PEFR/FV与BNP水平相关(r = -0.31;P < .001),与脉冲多普勒二尖瓣早期流入速度与多普勒组织成像瓣环速度之比E/E'相关(r = -0.54;P < .001)。

临床应用与阅片要点

  • 四维血流心脏MRI测得的PEFR/FV可作为评估肥厚型心肌病患者左心室充盈受损的指标,并与预后相关。
  • PEFR/FV≤2.61 sec⁻¹提示复合终点发生风险升高,独立于年龄、BNP水平、E/E'、LGE范围及左心室和左心房应变。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To investigate whether the peak early filling rate normalized to the filling volume (PEFR/FV) estimated from four-dimensional (4D) flow cardiac MRI may be used to assess impaired left ventricular (LV) filling and predict clinical outcomes in individuals with hypertrophic cardiomyopathy (HCM). Materials and Methods Cardiac MRI with a 4D flow sequence and late gadolinium enhancement (LGE), as well as echocardiography, was performed in 88 individuals: 44 participants with HCM from a French prospective registry (ClinicalTrials.gov; NCT01091480) and 44 healthy volunteers matched for age and sex. In participants with HCM, a composite primary end point was assessed at follow-up, including unexplained syncope, new-onset atrial fibrillation, hospitalization for congestive heart failure, ischemic stroke, sustained ventricular arrhythmia, septal reduction therapy, and cardiac death. A Cox proportional hazard model was used to analyze associations with the primary end point. Results PEFR/FV was significantly lower in the HCM group (mean age, 51.8 years ± 18.5 [SD]; 29 male participants) compared with healthy volunteers (mean, 3.35 sec-1 ± 0.99 [0.90-5.20] vs 4.42 sec-1 ± 1.68 [2.74-11.86]; P < .001) and correlated with both B-type natriuretic peptide (BNP) level (r = -0.31; P < .001) and the ratio of pulsed Doppler early transmitral inflow to Doppler tissue imaging annulus velocities (E/E'; r = -0.54; P < .001). At a median follow-up of 2.3 years (IQR, 1.7-3.3 years), the primary end point occurred in 14 (32%) participants. A PEFR/FV of 2.61 sec-1 or less was significantly associated with occurrence of the primary end point (hazard ratio, 9.46 [95% CI: 2.61, 45.17; P < .001] to 15.21 [95% CI: 3.51, 80.22; P < .001]), independently of age, BNP level, E/E', LGE extent, and LV and left atrial strain according to successive bivariate models. Conclusion In HCM, LV filling evaluated with 4D flow cardiac MRI correlated with Doppler and biologic indexes of diastolic dysfunction and predicted clinical outcomes. Keywords: Diastolic Function, Left Ventricular Filling, Hypertrophic Cardiomyopathy, Cardiac MRI, 4D Flow Sequence Clinical trial registration no. NCT01091480 Supplemental material is available for this article. © RSNA, 2024.

来源:Radiol Cardiothorac Imaging,查看原文。版权归原作者所有。

引用

  1. Sakhi H, Soulat G, Craiem D, et al. Association of Impaired Left Ventricular Mitral Filling from 4D Flow Cardiac MRI and Prognosis of Hypertrophic Cardiomyopathy. Radiol Cardiothorac Imaging. 2024. PMID: 38512023. doi:10.1148/ryct.230198

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。